Clinical Research Directory
Browse clinical research sites, groups, and studies.
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Sponsor: Ardeshir Rastinehad
Summary
This research study is designed to determine if targeted Magnetic Resonance Imaging (MRI) Ultrasound (US) fusion biopsy is better than the standard of care ultrasound guided biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist of comparing the standard of care (ultrasound guided prostate biopsy) with the protocol biopsy which consists of an ultrasound guided prostate biopsy and a MRI/US fusion tracked prostate biopsy.
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
564
Start Date
2020-08-21
Completion Date
2028-01-15
Last Updated
2026-11-20
Healthy Volunteers
No
Conditions
Interventions
Prostate Biopsy
Standard of care
MR US Fusion Guided Prostate Biopsy
Trans-rectal ultrasound (TRUS) guided fusion prostate biopsy (Arm 1) or a Transperineal Ultrasound guided fusion prostate biopsy (Arm 2). All patients will under go a standard ultrasound guided biopsy at the time of their targeted (fusion) biopsy.
MR/TRUS Fusion Guided Prostate Biopsy
TRUS images are overlaid on a previously obtained prostate MRI, combined with an electromagnetic tracking system. The urologist then performs directed prostate biopsies at MR-identified targets in addition to the standard prostate biopsies.
Locations (3)
The Smith Institute for Urology
Lake Success, New York, United States
The Smith Institute for Urology at Lenox Hill
New York, New York, United States
Manhattan Eye, Ear, and Throat Hospital (MEETH)
New York, New York, United States